VULVAR CARCINOMA
Clinical trials for VULVAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new VULVAR CARCINOMA trials appear
Sign up with your email to follow new studies for VULVAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy trial offers hope for advanced cancer patients out of options
Disease control OngoingThis study tested an immunotherapy drug called pembrolizumab in people with many different types of advanced solid tumors that had stopped responding to standard treatments. The main goal was to see if the drug could shrink tumors and to identify biological markers that might pre…
Matched conditions: VULVAR CARCINOMA
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Major trial aims to tame dozens of rare, neglected cancers with immune power combo
Disease control OngoingThis large national trial is testing whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) can help control over 50 different types of rare cancers that have few or no standard treatment options. It enrolled over 800 adults whose rare cancers had progressed …
Matched conditions: VULVAR CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Tracking life after radical cancer surgery
Knowledge-focused OngoingThis study aims to understand the recovery process for women who have a major surgery called pelvic exenteration to treat gynecologic cancers. Researchers are observing 79 women to see which surgical techniques lead to fewer complications and better long-term quality of life. The…
Matched conditions: VULVAR CARCINOMA
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC